Emergent Tricuspid Valve Replacement for Tricuspid Valve Endocarditis in a Chronic Hemodialysis Patient in Suriname

revealed a Abstract Tricuspid valve endocarditis caused by Acinetobacter baumannii is associated with a high mortality rate because of the bacterium’s resistance to almost all available antibiotics. Low and middle income countries (LMICs) face the challenge of successfully treating infective endocarditis because of the delayed diagnosis and having little access to expensive drug regimens. Although several international guidelines indicate that large vegetations on cardiac valve protheses require immediate surgery for valve replacement, this intervention remains a challenge in LMICs with limited resources. In our case, a hemodialysis patient developed tricuspid valve endocarditis due to A. Baumannii which was diagnosed at a late stage when surgery was necessary. Despite a few major complications, the patient survived. At the 2-year follow-up, she is still doing well.